Preventing the Preventable: Safe Mycophenolate Practices in Patients of Childbearing Potential

Transforming Cardiovascular Care: Uprooting Misperceptions and Therapeutic Inertia in Lipid Management

Diagnosing AD Early with SDM and Culturally Sensitive Care

Diagnosis of AD and Treatment with SDM

Discussions on Brain Health and Cognitive Concerns

A New Chapter in the ATTR Story: From Nihilism to Optimism

Digging Deeper into Abnormal Liver Test Results

Seeing the Unseen: Early Recognition and Individualized Management of Acromegaly

Pan-Viral Screening for HBV, HCV, and HIV in Diverse Practice Settings

The Force Awakens—Unlocking the Potential of IL-23–targeted Therapies in the Treatment of IBD

Initiating Basal Insulin: Moving from Hesitancy to Action

The Life-long Care of Individuals with Lennox-Gastaut Syndrome: Strategies for Outcomes Optimization from Childhood Through Adulthood

Unraveling the Options in First-line Maintenance of Ovarian Cancer

Bridging Gaps and Advancing Care in Sickle Cell Disease in the Context of Drug Therapy

Diagnostic and Therapeutic Advances in Primary Biliary Cholangitis: Maximizing Opportunities to Improve Patient Care and Outcomes

Who, What, and Why of Biomarker Testing in Ovarian Cancer

Optimizing Ulcerative Colitis Management: Navigating Challenges and Enhancing Outcomes in Managed Care

What’s IL-23 Got to Do With It? Targeted Therapies in the Management of IBD

How Low Can You Go? Targeting of Deep Remission in the Management of Crohn’s Disease

Why Are We Still Talking About the Mycophenolate REMS in 2024